FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...

Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the ...

FORT WORTH, Texas — Alcon’s ReStor multifocal IOL showed no difference in contrast sensitivity results from monofocal lenses, according to results of a multicenter trial. Almost 75% of patients ...

The net benefit of an apodized, diffractive presbyopia-correcting multifocal IOL exceeded its cost when compared with a conventional monofocal IOL. In a cost-benefit analysis, the multifocal IOL ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® family of intraocular lenses ...

First Preloaded Toric Available in the United States and Monofocal Option Combine Consistent IOL Delivery with Outstanding Visual Outcomes of enVista® LAVAL, QC, Oct. 27, 2020 /PRNewswire/ -- Bausch + ...

The following information should be reviewed with patients to ensure that they are aware of the available options. A written summary of the IOL options may also be given to patients to help with their ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available in select European ...

After bilateral cataract surgery, patients implanted with multifocal intraocular lenses (IOLs) were more likely to be spectacle-independent but also to undergo IOL exchange than those with monofocal ...

VAUGHAN, Ontario, September 11, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today ...